(KGC) Kinross Gold - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA4969024047
Stock:
Total Rating 71
Risk 56
Buy Signal 0.03
| Risk 5d forecast | |
|---|---|
| Volatility | 50.3% |
| Relative Tail Risk | -1.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.54 |
| Alpha | 204.02 |
| Character TTM | |
|---|---|
| Beta | 0.817 |
| Beta Downside | 1.175 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.15% |
| CAGR/Max DD | 5.08 |
EPS (Earnings per Share)
Revenue
Description: KGC Kinross Gold
Kinross Gold Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties principally in the United States, Brazil, Chile, Canada, and Mauritania. It is also involved in the extraction and processing of gold-containing ores; reclamation of gold mining properties; and production and sale of silver. The company was founded in 1993 and is headquartered in Toronto, Canada.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 2.40b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.21 > 0.02 and ΔFCF/TA 8.12 > 1.0 |
| NWC/Revenue: 26.70% < 20% (prev 18.76%; Δ 7.94% < -1%) |
| CFO/TA 0.30 > 3% & CFO 3.77b > Net Income 2.40b |
| Net Debt (-975.2m) to EBITDA (4.26b): -0.23 < 3 |
| Current Ratio: 2.35 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.21b) vs 12m ago -1.66% < -2% |
| Gross Margin: 49.30% > 18% (prev 0.36%; Δ 4894 % > 0.5%) |
| Asset Turnover: 60.76% > 50% (prev 47.41%; Δ 13.34% > 0%) |
| Interest Coverage Ratio: 38.25 > 6 (EBITDA TTM 4.26b / Interest Expense TTM 81.9m) |
Altman Z'' 0.81
| A: 0.15 (Total Current Assets 3.28b - Total Current Liabilities 1.40b) / Total Assets 12.39b |
| B: -0.48 (Retained Earnings -5.93b / Total Assets 12.39b) |
| C: 0.27 (EBIT TTM 3.13b / Avg Total Assets 11.62b) |
| D: -0.42 (Book Value of Equity -1.56b / Total Liabilities 3.71b) |
| Altman-Z'' Score: 0.81 = B |
Beneish M -2.92
| DSRI: 1.35 (Receivables 84.0m/45.5m, Revenue 7.06b/5.15b) |
| GMI: 0.74 (GM 49.30% / 36.48%) |
| AQI: 0.84 (AQ_t 0.07 / AQ_t-1 0.08) |
| SGI: 1.37 (Revenue 7.06b / 5.15b) |
| TATA: -0.11 (NI 2.40b - CFO 3.77b) / TA 12.39b) |
| Beneish M-Score: -2.92 (Cap -4..+1) = A |
What is the price of KGC shares?
As of March 05, 2026, the stock is trading at USD 33.80 with a total of 13,591,794 shares traded.
Over the past week, the price has changed by -6.27%, over one month by +1.50%, over three months by +24.59% and over the past year by +217.13%.
Over the past week, the price has changed by -6.27%, over one month by +1.50%, over three months by +24.59% and over the past year by +217.13%.
Is KGC a buy, sell or hold?
Kinross Gold has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy KGC.
- StrongBuy: 6
- Buy: 5
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the KGC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40 | 18.3% |
| Analysts Target Price | 40 | 18.3% |
KGC Fundamental Data Overview February 28, 2026
P/E Trailing = 18.9692
P/E Forward = 12.0192
P/S = 6.3299
P/B = 5.143
P/EG = -3.9
Revenue TTM = 7.06b USD
EBIT TTM = 3.13b USD
EBITDA TTM = 4.26b USD
Long Term Debt = 738.2m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 777.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -975.2m USD (from netDebt column, last quarter)
Enterprise Value = 43.66b USD (44.63b + Debt 777.4m - CCE 1.75b)
Interest Coverage Ratio = 38.25 (Ebit TTM 3.13b / Interest Expense TTM 81.9m)
EV/FCF = 16.99x (Enterprise Value 43.66b / FCF TTM 2.57b)
FCF Yield = 5.89% (FCF TTM 2.57b / Enterprise Value 43.66b)
FCF Margin = 36.39% (FCF TTM 2.57b / Revenue TTM 7.06b)
Net Margin = 33.95% (Net Income TTM 2.40b / Revenue TTM 7.06b)
Gross Margin = 49.30% ((Revenue TTM 7.06b - Cost of Revenue TTM 3.58b) / Revenue TTM)
Gross Margin QoQ = 52.43% (prev 47.43%)
Tobins Q-Ratio = 3.52 (Enterprise Value 43.66b / Total Assets 12.39b)
Interest Expense / Debt = 2.73% (Interest Expense 21.2m / Debt 777.4m)
Taxrate = 16.83% (187.5m / 1.11b)
NOPAT = 2.61b (EBIT 3.13b * (1 - 16.83%))
Current Ratio = 2.35 (Total Current Assets 3.28b / Total Current Liabilities 1.40b)
Debt / Equity = 0.09 (Debt 777.4m / totalStockholderEquity, last quarter 8.56b)
Debt / EBITDA = -0.23 (Net Debt -975.2m / EBITDA 4.26b)
Debt / FCF = -0.38 (Net Debt -975.2m / FCF TTM 2.57b)
Total Stockholder Equity = 7.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.63% (Net Income 2.40b / Total Assets 12.39b)
RoE = 30.66% (Net Income TTM 2.40b / Total Stockholder Equity 7.82b)
RoCE = 36.61% (EBIT 3.13b / Capital Employed (Equity 7.82b + L.T.Debt 738.2m))
RoIC = 29.17% (NOPAT 2.61b / Invested Capital 8.93b)
WACC = 8.82% (E(44.63b)/V(45.41b) * Re(8.93%) + D(777.4m)/V(45.41b) * Rd(2.73%) * (1-Tc(0.17)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.08%
[DCF] Terminal Value 78.65% ; FCFF base≈2.09b ; Y1≈2.58b ; Y5≈4.39b
[DCF] Fair Price = 53.86 (EV 63.65b - Net Debt -975.2m = Equity 64.62b / Shares 1.20b; r=8.82% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 94.54 | EPS CAGR: 90.30% | SUE: 1.50 | # QB: 4
Revenue Correlation: 97.08 | Revenue CAGR: 33.21% | SUE: 2.61 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.76 | Chg7d=-0.082 | Chg30d=+0.041 | Revisions Net=+2 | Analysts=5
EPS current Year (2026-12-31): EPS=2.95 | Chg7d=+0.040 | Chg30d=+0.282 | Revisions Net=+6 | Growth EPS=+60.5% | Growth Revenue=+36.2%
EPS next Year (2027-12-31): EPS=3.11 | Chg7d=+0.010 | Chg30d=+0.342 | Revisions Net=+4 | Growth EPS=+5.3% | Growth Revenue=-1.4%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.7% (Discount Rate 8.9% - Earnings Yield 5.3%)
[Growth] Growth Spread = +48.4% (Analyst 52.1% - Implied 3.7%)
P/E Forward = 12.0192
P/S = 6.3299
P/B = 5.143
P/EG = -3.9
Revenue TTM = 7.06b USD
EBIT TTM = 3.13b USD
EBITDA TTM = 4.26b USD
Long Term Debt = 738.2m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 777.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -975.2m USD (from netDebt column, last quarter)
Enterprise Value = 43.66b USD (44.63b + Debt 777.4m - CCE 1.75b)
Interest Coverage Ratio = 38.25 (Ebit TTM 3.13b / Interest Expense TTM 81.9m)
EV/FCF = 16.99x (Enterprise Value 43.66b / FCF TTM 2.57b)
FCF Yield = 5.89% (FCF TTM 2.57b / Enterprise Value 43.66b)
FCF Margin = 36.39% (FCF TTM 2.57b / Revenue TTM 7.06b)
Net Margin = 33.95% (Net Income TTM 2.40b / Revenue TTM 7.06b)
Gross Margin = 49.30% ((Revenue TTM 7.06b - Cost of Revenue TTM 3.58b) / Revenue TTM)
Gross Margin QoQ = 52.43% (prev 47.43%)
Tobins Q-Ratio = 3.52 (Enterprise Value 43.66b / Total Assets 12.39b)
Interest Expense / Debt = 2.73% (Interest Expense 21.2m / Debt 777.4m)
Taxrate = 16.83% (187.5m / 1.11b)
NOPAT = 2.61b (EBIT 3.13b * (1 - 16.83%))
Current Ratio = 2.35 (Total Current Assets 3.28b / Total Current Liabilities 1.40b)
Debt / Equity = 0.09 (Debt 777.4m / totalStockholderEquity, last quarter 8.56b)
Debt / EBITDA = -0.23 (Net Debt -975.2m / EBITDA 4.26b)
Debt / FCF = -0.38 (Net Debt -975.2m / FCF TTM 2.57b)
Total Stockholder Equity = 7.82b (last 4 quarters mean from totalStockholderEquity)
RoA = 20.63% (Net Income 2.40b / Total Assets 12.39b)
RoE = 30.66% (Net Income TTM 2.40b / Total Stockholder Equity 7.82b)
RoCE = 36.61% (EBIT 3.13b / Capital Employed (Equity 7.82b + L.T.Debt 738.2m))
RoIC = 29.17% (NOPAT 2.61b / Invested Capital 8.93b)
WACC = 8.82% (E(44.63b)/V(45.41b) * Re(8.93%) + D(777.4m)/V(45.41b) * Rd(2.73%) * (1-Tc(0.17)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.08%
[DCF] Terminal Value 78.65% ; FCFF base≈2.09b ; Y1≈2.58b ; Y5≈4.39b
[DCF] Fair Price = 53.86 (EV 63.65b - Net Debt -975.2m = Equity 64.62b / Shares 1.20b; r=8.82% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 94.54 | EPS CAGR: 90.30% | SUE: 1.50 | # QB: 4
Revenue Correlation: 97.08 | Revenue CAGR: 33.21% | SUE: 2.61 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.76 | Chg7d=-0.082 | Chg30d=+0.041 | Revisions Net=+2 | Analysts=5
EPS current Year (2026-12-31): EPS=2.95 | Chg7d=+0.040 | Chg30d=+0.282 | Revisions Net=+6 | Growth EPS=+60.5% | Growth Revenue=+36.2%
EPS next Year (2027-12-31): EPS=3.11 | Chg7d=+0.010 | Chg30d=+0.342 | Revisions Net=+4 | Growth EPS=+5.3% | Growth Revenue=-1.4%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.7% (Discount Rate 8.9% - Earnings Yield 5.3%)
[Growth] Growth Spread = +48.4% (Analyst 52.1% - Implied 3.7%)